Methyl 2-[(1,3-benzothiazol-2-yl)methoxy]acetate
Structure Info
- Chemspace ID
- CSSB00103344529 (In-Stock Building Blocks)
- CAS
- 101451-14-3
- IUPAC Name
- methyl 2-[(1,3-benzothiazol-2-yl)methoxy]acetate
- Mol formula
- C11H11NO3S
- Mol weight
- 237 Da
- Catalog Number(s)
- BBLS00103344529, BBV-47033918, CSC005654755, CSC103344529, CSCR00005654755, EN300-39664645, Z92702070, bbls00103344529, s_1458_478426_483916, s_1458____478426____483916
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.69
- Heavy atoms count
- 16
- Rotatable bond count
- 5
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.272
- Polar surface area (Å)
- 48
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of Methyl 2-[(1,3-benzothiazol-2-yl)methoxy]acetate (C11H11NO3S) - CSSB00103344529](/st/structure/200/7e52ab15b149447633f71561a247be73/COC%2528%253DO%2529COCC1%253DNC2%253DCC%253DCC%253DC2S1.png "C11H11NO3S")
- Zoom the structure
- CSSB00103344529
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 455.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 477.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 498.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 519.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of ethyl 2-[(1,3-benzothiazol-2-yl)methoxy]acetate - CSSB01997893989](/st/structure/200/831cdee9003e367e19f13f95622ad362/CCOC%2528%253DO%2529COCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
Similarity Analogs
![Chemical structure of 2-[(1,3-benzothiazol-2-yl)methoxy]-N,N-dimethylacetamide - CSSB00026574390](/st/structure/200/9d0654b5863ee5e50bd1654d6828582b/CN%2528C%2529C%2528%253DO%2529COCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of 2-[(1,3-benzothiazol-2-yl)methoxy]-N-methoxy-N-methylacetamide - CSSB02005135749](/st/structure/200/ccff20fc910fc35fbe9b208cd4f6e9e0/CON%2528C%2529C%2528%253DO%2529COCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of 2-[(1,3-benzothiazol-2-yl)methoxy]-N-methylacetamide - CSSB01994031623](/st/structure/200/d8eacc3fca4b9e10a586885c63c5d3a0/CNC%2528%253DO%2529COCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of 2-[(1,3-benzothiazol-2-yl)methoxy]acetamide - CSSB00081123760](/st/structure/200/2287aef5ceb215e93ea89cb27731e9e8/NC%2528%253DO%2529COCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
